Tag: biotherapeutics

September 30, 2019 Off

Horizon Discovery, Glenmark Pharmaceuticals ink license agreement for GS knockout CHO cell line for manufacture of biotherapeutics

Glenmark signs full commercial-use license for Horizon’s gene-edited CHO cells CAMBRIDGE, England–(BUSINESS WIRE)–Horizon Discovery Group plc (LSE: HZD) (“Horizon”), a…

April 8, 2019 Off

Applied DNA Subsidiary LineaRx Achieves Biotech Industry First with Anti-CD19 Expression in Human CAR T Cells via Proprietary Non-Viral, Plasmid-Free Platform

By BusinessWire

Novel DNA Manufacturing Platform Seeks to Pioneer New Generation of Faster, More Affordable Cell-based Therapeutics for Patients STONY BROOK, N.Y.–(BUSINESS…